28 JULY 2026
Estimated reading time : 8 Minutes
Will AI Reduce Healthcare Claim Denials by 50% Before 2027?
A few years ago, denial management meant a back-office team quietly working through a stack of rejected claims. In 2026, it’s a board-level conversation. Denials have become one of the clearest signals of how exposed a healthcare organization’s revenue cycle really is and AI is the technology everyone is betting on to fix it.
So here’s the question every CFO and Revenue Cycle leader is actually asking: can AI realistically cut claim denials in half by 2027? Not on a vendor’s roadmap slide in production, across real claim volumes, with real payers. The answer is more nuanced than the marketing decks suggest.
The State of Healthcare Claim Denials in 2026.
Denials aren’t trending in the direction anyone wants. Hospital claim denials reached an average of 11.6% in 2025, driving $48.4 billion in revenue leakage in a single year. Initial claim denials hit 11.8% in 2024, up from 10.2% just a few years earlier, and Kodiak Solutions’ analysis of more than 2,300 hospitals found every tracked denial metric increased year-over-year a sign the problem is structural, not seasonal.
On the provider side, Experian Health’s 2025 State of Claims report found 41% of revenue cycle leaders face denial rates of at least 10%. On the payer side, KFF’s review of CMS data found ACA Marketplace denial rates improved slightly, from 22.5% in 2023 to 19.1% in 2024, yet roughly 8.8 million of 46 million in-network claims were still denied in that period.
AI isn’t being asked to fix a 2-3% denial problem. It’s being asked to bend a curve that has climbed for several consecutive years, against payers that are becoming more automated themselves.
What percentage of claim denials are preventable?
Industry estimates put the preventable share of denials between 65-90%. KFF’s review of ACA Marketplace data found that three in four denials (77%) stem from paperwork or plan design issues, not medical judgment meaning most denials trace back to fixable, upstream process failures.
Why Denials Keep Rising Despite Years of Tech Investment
Payers Are Automating Faster Than Providers
Payers have moved quicker into AI-driven claims adjudication than providers. There are growing reports of inaccurate automated denials, including one widely reported case where over 300,000 claims were allegedly denied in under two months. When the reviewing side automates faster than the submitting side, denial rates rise almost by definition.
Coding Complexity Is Accelerating
2026 brought one of the largest single-year coding overhauls in recent memory: CMS added 288 new CPT codes, deleted 84, and revised 46 more, on top of an October 2025 ICD-10-CM update adding 614 new codes. Every change is a fresh chance for a claim to go out mismatched and a fresh reason for a payer to reject it.
AI Adoption Is Real, But Still Early
According to HFMA and FinThrive, 63% of healthcare organizations have integrated AI-powered automation into claims processing, though only 15% report a clear positive ROI so far. The gap is sharper within denials specifically: a 2025 Bain & Co. survey found only about one in five providers apply AI directly to denials management, even as adoption races ahead in documentation and coding.
What is AI-powered denial management?
Featured Snippet Answer: AI-powered denial management uses machine learning to identify claims at risk of denial before submission, flag documentation or coding gaps in real time, and prioritize denied claims for appeal. Instead of reacting after a payer rejects a claim, AI shifts the work upstream toward prevention using patterns learned from historical claims and payer behavior.
Predictive Prevention vs. Traditional Denial Management
Traditional denial management is reactive: a claim gets denied, a biller investigates, and it’s corrected or appealed. Necessary, but expensive industry estimates put the cost to rework a denied claim at $25-$181, before accounting for delayed cash flow.
Predictive prevention flips the sequence. AI scores claims for denial risk before submission, checking eligibility, authorization status, and documentation completeness against patterns from prior claims. HFMA describes leading organizations running real-time eligibility checks with predictive risk scoring at registration, surfacing high-risk scenarios days before a payer decision.
The performance gap is real. Practices that prioritize prevention over remediation report denial rates 30–50% lower than peers who haven’t made the shift suggesting a 50% relative reduction is already achievable for organizations executing well. The harder question is whether that generalizes industry-wide by 2027.
How does AI improve clean claim rates?
Featured Snippet Answer: AI improves clean claim rates by validating eligibility, coding, and documentation in real time before a claim leaves the building. Organizations using AI-driven claim scrubbing report clean claim rates of 95–98%, compared to an 85–90% national average for those relying on manual or rule-based checks alone.
Where AI Is Already Proving Itself
Of providers using AI in claims and denials, 69% say it has boosted claims success either reducing denials outright or improving resubmission rates. That figure shows up consistently across multiple Experian Health surveys.
McKinsey’s analysis, cited by HFMA, frames the opportunity in cost terms: AI in the revenue cycle could cut cost-to-collect by 30–60% and accelerate cash realization. Adoption is moving fast too HFMA’s February 2026 survey found 27% of organizations now deploying AI at scale, with another 53% running pilots.
Can AI reduce healthcare claim denials?
Featured Snippet Answer: Yes AI is already reducing denials where it’s implemented well, with 69% of current AI users reporting measurable improvement in claims success. Results vary based on data quality and governance, and on whether AI is embedded into front-end workflows like eligibility verification, not just back-end appeals.
The Honest Limitations
A balanced view has to include the friction. HFMA’s own survey found just over half of revenue cycle leaders feel only “somewhat” or “very” prepared for an AI-enabled future a real readiness gap. Denials management itself lags other AI use cases; providers have invested more in ambient documentation and coding than in denials.
Prior authorization remains a stubborn edge case: when a physician switches procedures mid-treatment, a claim can be denied even with prior authorization on file, since the payer requires reauthorization a nuance AI can’t yet negotiate. Governance can’t be skipped either: poorly trained models can embed bias, and overreliance on generative outputs without review risks non-compliant submissions. Tellingly, 63% of hospital leaders admit they aren’t yet taking a proactive approach to revenue risk, even as AI investment rises.
So, Will AI Cut Denials by 50% Before 2027?
At the organizational level, it’s already happening for some. Organizations committed to AI-driven, prevention-first denial management report denial rates 30-50% lower than peers for a well-resourced system with strong data and governance, halving denials by 2027 is realistic.
At the industry level, a uniform 50% reduction is unlikely. National denial rates have been rising, not falling, for years. AI adoption within denials management specifically still sits around one in five providers, and readiness remains mixed. Payers are deploying their own AI in parallel providers aren’t racing toward a fixed target, they’re racing against a moving one.
The more realistic forecast is a widening performance gap, not a uniform industry-wide halving. AI-mature organizations will likely hit 30–50%+ reductions by 2027; those still in pilot mode will see far more modest gains, and may keep losing ground to payer-side automation. Fifty percent is achievable it just won’t be the average outcome. It’ll belong to organizations treating denial prevention as a strategic discipline starting now.
What Healthcare Leaders Should Do Now
Shift budget from denial management to denial prevention rework costs $25-$181 per claim, while upstream checks cost a fraction of that. Build human-in-the-loop review into every AI-assisted denial workflow before scaling it. Close the visibility gap first: with nearly two-thirds of hospital leaders lacking proactive revenue risk visibility, better instrumentation often matters more than another tool. Prioritize the use cases with the clearest evidence eligibility verification, coding validation, and triage of high-dollar denials for appeal rather than spreading investment thin. And benchmark against payer mix and care setting, not national averages, since denial drivers differ sharply across settings.
Viaante is a healthcare revenue cycle management partner that works alongside U.S. providers, hospitals, and physician groups to strengthen financial performance across the claims lifecycle, supporting denial management services that address both the upstream causes of preventable denials and the downstream work of resolving claims that do get rejected.
Rather than treating denial management as an isolated function, Viaante’s approach centers on operational efficiency, revenue integrity, and long-term financial performance helping organizations close the gap between today’s revenue cycle and where AI-enabled best practices are heading by 2027.
